WOLVERINE TRADING, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 142 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16,092
-24.0%
14,900
-5.7%
0.00%
Q2 2023$21,172
+78314.8%
15,800
-22.5%
0.00%
Q1 2023$27
-99.9%
20,400
-2.9%
0.00%
Q3 2022$25,000
-39.0%
21,000
+53.3%
0.00%
Q1 2022$41,000
-47.4%
13,700
-53.2%
0.00%
Q4 2021$78,000
-46.6%
29,300
-26.9%
0.00%
Q3 2021$146,000
-52.9%
40,100
-42.5%
0.00%
Q2 2021$310,000
+8.8%
69,700
-16.9%
0.00%
Q1 2021$285,000
+31.9%
83,883
+40.5%
0.00%
Q4 2020$216,000
+80.0%
59,700
+15.2%
0.00%
Q3 2020$120,000
+471.4%
51,812
+350.5%
0.00%
Q2 2020$21,000
-87.1%
11,500
-84.1%
0.00%
Q4 2018$163,000
-37.5%
72,479
-10.8%
0.00%
Q3 2018$261,000
+20.3%
81,258
+32.4%
0.00%
Q2 2018$217,0000.0%61,3610.0%0.00%
Q1 2018$217,000
+1.4%
61,361
+11.6%
0.00%
Q4 2017$214,000
+86.1%
54,967
+20.8%
0.00%
Q3 2017$115,000
+43.8%
45,500
+59.6%
0.00%
Q2 2017$80,000
-73.3%
28,500
-65.9%
0.00%
-100.0%
Q3 2016$300,000
+50.8%
83,699
-9.1%
0.00%
+100.0%
Q2 2016$199,00092,0670.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders